Literature DB >> 7398729

Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

T Jogestrand.   

Abstract

Serum, right atrial myocardium and skeletal muscle collected from 32 adult patients undergoing open heart surgery were analyzed for digoxin by radioimmunoassay. Preoperatively 20 patients were in sinus rhythm, but not in patients with atrial fibrillation, there was a highly significant correlation between digoxin concentration in serum and right atrial myocardium, in skeletal muscle and right atrial myocardium, and in serum and skeletal muscle. The means and variances of the ratios right atrial myocardium/serum and right atrial myocardium skeletal muscle were significantly higher in patients with atrial fibrillation than in those with sinus rhythm. This, plus the lack of difference in ratios skeletal muscle serum between these groups of patients, indicate increased right atrial digoxin binding in atrial fibrillation in man. This conclusion is further supported by the finding of similar or higher digoxin concentration in right atrial myocardium than in left ventricular myocardium in atrial fibrillation (6 patients), and a lower digoxin concentration in right atrial myocardium than in left ventricular myocardium in sinus rhythm (3 patients).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398729     DOI: 10.1007/bf00625797

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Tissue concentrations of digoxin in an autopsy material.

Authors:  J Karjalainen; K Ojala; P Reissell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-05

2.  Myocardial distribution of digoxin and renal function.

Authors:  W J Jusko; M Weintraub
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

3.  Correlation of serum concentrations with heart concentrations of digoxin in human subjects.

Authors:  H G Güllner; E B Stinson; D C Harrison; S M Kalman
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

4.  Physiological distribution of digoxin in human heart.

Authors:  D J Coltart; H G Güllner; M Billingham; R H Goldman; E B Stinson; S M Kalman; D C Harrison
Journal:  Br Med J       Date:  1974-12-28

5.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Relationship among contraction, drug binding and positive inotropic action of digoxin.

Authors:  B F Roth-Schechter; G T Okita; D Anderson; F Richardson
Journal:  J Pharmacol Exp Ther       Date:  1970-02       Impact factor: 4.030

7.  A previously unrecognized drug interaction between quinidine and digoxin.

Authors:  J A Reiffel; E B Leahey; R E Drusin; R H Heissenbuttel; W Lovejoy; J T Bigger
Journal:  Clin Cardiol       Date:  1979-02       Impact factor: 2.882

8.  Accumulation and release of 3H-digoxin by guinea-pig heart muscle.

Authors:  K Kuschinsky; H Lahrtz; H Lüllmann; P A van Zwieten
Journal:  Br J Pharmacol Chemother       Date:  1967-06

9.  Human serum and myocardium digoxin.

Authors:  G Härtel; K Kyllönen; E Merikallio; K Ojala; V Manninen; P Reissell
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

10.  Human myocardium and plasma digoxin concentration in patients on long-term digoxin therapy.

Authors:  J Lichey; C Havestatt; J Weinmann; J Hasford; N Rietbrock
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-10
View more
  15 in total

1.  Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.

Authors:  H E Bøtker; P Toft; N A Klitgaard; E E Simonsen
Journal:  Br Heart J       Date:  1991-06

2.  Usefulness of diltiazem in the acute management of supraventricular tachyarrhythmias in the elderly.

Authors:  A Millaire; O Leroy; P de Groote; C Santré; G Ducloux
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  Oral salbutamol decreases serum digoxin concentration.

Authors:  M Edner; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Effect of salbutamol on digoxin concentration in serum and skeletal muscle.

Authors:  M Edner; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

6.  Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Skeletal muscle digoxin binding in patients with renal failure.

Authors:  T Jogestrand; F Ericsson
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

9.  Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.

Authors:  T Jogestrand; F Ericsson; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

10.  Skeletal muscle binding and renal excretion of digoxin in man.

Authors:  K Schenck-Gustafsson; T Jogestrand; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.